|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Trade and other receivables, net of allowance for credit losses of $65 million and $79 million, respectively | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Indemnification agreement receivable | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment | ||||||||||||||||||||
| Accumulated depreciation | ||||||||||||||||||||
| Property and equipment, net of accumulated depreciation of $980 million and $974 million, respectively | ||||||||||||||||||||
| Trademarks and Trade Names | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Tradenames | ||||||||||||||||||||
| Intangible assets not subject to amortization | ||||||||||||||||||||
| Intangible assets not subject to amortization, total | ||||||||||||||||||||
| Intangible assets subject to amortization, net (note 6) | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Other assets, at cost, net of accumulated amortization | ||||||||||||||||||||
| Assets held for sale noncurrent (note 9) | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Equity | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||||
| Current portion of debt, $0 million and $52 million measured at fair value (note 7), respectively | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt (note 7) | ||||||||||||||||||||
| Deferred income tax liabilities | ||||||||||||||||||||
| Preferred stock (note 8) | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Liabilities Subject to Compromise | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' equity: | ||||||||||||||||||||
| Common stock value | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive earnings (loss), net of taxes | ||||||||||||||||||||
| Retained earnings (accumulated deficit) | ||||||||||||||||||||
| Total stockholders' equity (deficit) | ||||||||||||||||||||
| Noncontrolling interests in equity of subsidiaries | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Liabilities and Equity |
Loading...
